(Q43148419)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187107%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187107%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

liver transplantation

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187107%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1

Christian Toso

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187107%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

3

David L Bigam

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187107%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

5

Norman M Kneteman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187107%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

A M James Shapiro

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187107%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

1 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187107%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187107%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187107%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187107%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

1237-1243

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187107%20AND%20SRC:MED&resulttype=core&format=json

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

18 January 2020

cites work

1 reference

Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria

21 January 2018

1 reference

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

21 January 2018

1 reference

Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma

21 January 2018

1 reference

Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database

21 January 2018

1 reference

Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence

21 January 2018

1 reference

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

21 January 2018

1 reference

Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation

21 January 2018

1 reference

Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF.

21 January 2018

1 reference

Inhibition of mTOR in combination with doxorubicin in an experimental model of hepatocellular carcinoma

21 January 2018

1 reference

Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma

21 January 2018

1 reference

Sirolimus inhibits growth of human hepatoma cells alone or combined with tacrolimus, while tacrolimus promotes cell growth

21 January 2018

1 reference

De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects.

21 January 2018

1 reference

Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.

21 January 2018

1 reference

Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria

21 January 2018

1 reference

Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma

21 January 2018

1 reference

The estimated number of patients with hepatocellular carcinoma selected for liver transplantation using expanded selection criteria

21 January 2018

1 reference

Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications

21 January 2018

1 reference

A retrospective review of liver transplant patients treated with sirolimus from a single center: an analysis of sirolimus-related complications

21 January 2018

1 reference

Incisional hernia following liver transplantation: incidence and predisposing factors

21 January 2018

1 reference

Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/HEP.23437

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187107%20AND%20SRC:MED&resulttype=core&format=json

release_6opyuq3htffrjphxm6gaftva2u

18 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6opyuq3htffrjphxm6gaftva2u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference